Technology
M&A Advisory
Pharmaceutical
M&A Advisory
Lazard
Full Credential Description
ARIAD Pharmaceuticals. United States. Announced Date 05/08/2005. Closed Date 10/08/2005. Deal value: $54m. Common stock. Industry: ARIAD Pharmaceuticals is a biotechnology company focused on the discovery and development of breakthrough medicines to treat cancer.